These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 6580488

  • 1. Urinary excretion of beta-aminoisobutyrate and pseudouridine in acute and chronic myeloid leukemia.
    Nielsen HR, Killmann SA.
    J Natl Cancer Inst; 1983 Nov; 71(5):887-91. PubMed ID: 6580488
    [Abstract] [Full Text] [Related]

  • 2. Urinary pseudouridine and beta-aminoisobutyric acid in patients with low grade urothelial tumours. Relations between excretion and tumour recurrence.
    Nyholm KK, Sjolin KE, Wolf H, Hammer M, Knudsen J, Stahl D, Nielsen HR.
    Biomedicine; 1976 May; 25(3):85-7. PubMed ID: 949520
    [Abstract] [Full Text] [Related]

  • 3. Excretion patterns of pseudouridine and beta-aminoisobutyric acid in patients with tumours of the upper urinary tract.
    Kvist E, Sjølin KE, Iversen J.
    Scand J Urol Nephrol; 1990 May; 24(4):287-92. PubMed ID: 2274753
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Combination of liposomal daunorubicin (DaunoXome), fludarabine, and cytarabine (FLAD) in patients with poor-risk acute leukemia.
    Clavio M, Venturino C, Pierri I, Garrone A, Miglino M, Canepa L, Balleari E, Balocco M, Michelis GL, Ballerini F, Gobbi M.
    Ann Hematol; 2004 Nov; 83(11):696-703. PubMed ID: 15322763
    [Abstract] [Full Text] [Related]

  • 7. Urinary excretion of modified nucleosides in chronic myelogenous leukemia.
    Heldman DA, Grever MR, Speicher CE, Trewyn RW.
    J Lab Clin Med; 1983 May; 101(5):783-92. PubMed ID: 6572681
    [Abstract] [Full Text] [Related]

  • 8. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
    Engelhardt M, Mackenzie K, Drullinsky P, Silver RT, Moore MA.
    Cancer Res; 2000 Feb 01; 60(3):610-7. PubMed ID: 10676644
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A study on the clinical significance of urinary beta-aminoisobutyric acid in patients with urothelial tumours.
    Nyholm KK, Sjölin KE, Hammer M, Knudsen J, Stahl D, Nielsen HR.
    Biomedicine; 1975 Nov 01; 22(6):509-16. PubMed ID: 1225382
    [Abstract] [Full Text] [Related]

  • 15. Pseudouridine excretion in patients with psoriasis.
    Clemmensen OJ, Kieffer M, Sjølin KE.
    Acta Derm Venereol; 1987 Nov 01; 67(4):310-4. PubMed ID: 2445149
    [Abstract] [Full Text] [Related]

  • 16. Correlations of beta-aminoisobutyric acid in 8 hour and 24 hour urinary samples determined by dual column gas chromatography.
    Sjölin KE, Nyholm KK.
    Biomedicine; 1980 May 01; 32(2):60-5. PubMed ID: 7388117
    [Abstract] [Full Text] [Related]

  • 17. [Pseudouridine and uric acid excretion in patients with viral hepatitis].
    Lifshits RI, Salomatin VV, Efimenko GP.
    Vopr Med Khim; 1976 May 01; 22(5):687-90. PubMed ID: 1014482
    [Abstract] [Full Text] [Related]

  • 18. Different immune reconstitution in multiple myeloma, chronic myeloid leukemia and acute myeloid leukemia patients after allogeneic transplantation of peripheral blood stem cells.
    Rondelli D, Re F, Bandini G, Raspadori D, Arpinati M, Senese B, Stanzani M, Bonifazi F, Falcioni S, Chirumbolo G, Tura S.
    Bone Marrow Transplant; 2000 Dec 01; 26(12):1325-31. PubMed ID: 11223973
    [Abstract] [Full Text] [Related]

  • 19. Urinary excretion patterns of pseudouridine and beta-aminoisobutyric acid in patients with tumours of the urinary bladder.
    Kvist E, Sjølin KE, Iversen J, Nyholm K.
    Scand J Urol Nephrol; 1993 Dec 01; 27(1):45-53. PubMed ID: 8493467
    [Abstract] [Full Text] [Related]

  • 20. Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients.
    Klobusická M, Kusenda J, Babusíková O.
    Neoplasma; 2003 Dec 01; 50(6):408-15. PubMed ID: 14689061
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.